Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 1,515 | 1,809 | 3,764 | 2,038 | 3,334 |
| Operating Income | -1,515 | -1,809 | -3,764 | -2,038 | -3,334 |
| Interest Expense | 603 | 445 | 434 | 521 | 381 |
| Other Income | 146 | 399 | 630 | -564 | -194 |
| Pre-tax Income | -1,971 | -1,856 | -3,568 | -3,123 | -3,909 |
| Net Income Continuous | -1,971 | -1,856 | -3,568 | -3,123 | -3,909 |
| Minority Interests | -177 | -293 | -337 | -320 | N/A |
| Net Income | $-1,794 | $-1,563 | $-3,231 | $-2,803 | $-3,440 |
| EPS Basic Total Ops | 0.01 | 0.00 | -0.01 | -0.03 | -0.05 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | -0.01 | -0.03 | -0.04 |
| EPS Diluted Total Ops | 0.01 | 0.00 | -0.01 | -0.03 | -0.05 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.01 | -0.03 | -0.04 |
| EBITDA(a) | $-1,105 | $-1,471 | $-3,433 | $-1,601 | $-3,513 |